Margaret Woch

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase 2, randomized multi oral immunotherapy with omalizumab ‘real life’ study”.

Phase 2, randomized multi oral immunotherapy with omalizumab ‘real life’ study

Allergy(2022)10.1111/all.15217

N/A

1.1DataRank · unranked

48 citations

Divya Kumar, Shu Cao, Natasha Purington, Andrew Long, Vanitha Sampath +5 more

Retail Food Equivalents for Post–Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical Trial

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.10.022

N/A

0DataRank · unranked

23 citations

Kim Mudd, Margaret Woch, Allison Schaible, Brianna E Gray, Denise C. Babineau +14 more

Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIF

Frontiers in Allergy(2025)10.3389/falgy.2025.1458131

N/A

0DataRank · unranked

0 citations

Shu Cao, Kristine Martinez, Reyna Sharma, Olivia Raeber, Andrea Fernandes +13 more